Rafferty Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,410
| Closed | -$2.06M | – | 1096 |
|
|
2023
Q1 | $2.06M | Buy |
28,410
+2,419
| +9% | +$175K | 0.01% | 605 |
|
|
2022
Q4 | $2.13M | Sell |
25,991
-960
| -4% | -$78.7K | 0.02% | 556 |
|
|
2022
Q3 | $2.55M | Buy |
26,951
+11,434
| +74% | +$1.08M | 0.03% | 456 |
|
|
2022
Q2 | $3.02M | Buy |
15,517
+34
| +0.2% | +$6.62K | 0.03% | 386 |
|
|
2022
Q1 | $3.6M | Buy |
15,483
+5,366
| +53% | +$1.25M | 0.02% | 459 |
|
|
2021
Q4 | $3.99M | Buy |
10,117
+5,208
| +106% | +$2.05M | 0.02% | 464 |
|
|
2021
Q3 | $2.2M | Sell |
4,909
-1,415
| -22% | -$633K | 0.02% | 614 |
|
|
2021
Q2 | $2.46M | Sell |
6,324
-1,561
| -20% | -$607K | 0.02% | 614 |
|
|
2021
Q1 | $2.83M | Buy |
7,885
+7,023
| +815% | +$2.52M | 0.02% | 527 |
|
|
2020
Q4 | $423K | Sell |
862
-1,991
| -70% | -$977K | ﹤0.01% | 719 |
|
|
2020
Q3 | $924K | Buy |
2,853
+1,408
| +97% | +$456K | 0.01% | 587 |
|
|
2020
Q2 | $526K | Buy |
+1,445
| New | +$526K | 0.01% | 700 |
|
|
2020
Q1 | – | Sell |
-2,528
| Closed | -$1.04M | – | 615 |
|
|
2019
Q4 | $1.04M | Sell |
2,528
-3,977
| -61% | -$1.64M | 0.02% | 542 |
|
|
2019
Q3 | $2.3M | Buy |
6,505
+1,725
| +36% | +$609K | 0.04% | 312 |
|
|
2019
Q2 | $2.4M | Buy |
4,780
+2,184
| +84% | +$1.1M | 0.04% | 317 |
|
|
2019
Q1 | $2.58M | Buy |
+2,596
| New | +$2.58M | 0.04% | 275 |
|